2019 Abstract Guidelines


Submit Abstract


Abstract FAQs

Abstract Guidelines

Scientific material must be original and not previously published, nor currently accepted for publication or presentation at another meeting prior to the USCAP 2018 Annual Meeting. You may submit as many abstracts as you wish; however, no more than three abstracts will be accepted from any first author. There is no limit for co-authorship. Abstracts are blinded for review. Please do not include identifying information in the body of the abstract (such as institutional names). View the complete rules and submission guidelines below.

Abstract Eligibility

All abstracts submitted to the USCAP 2019 Annual Meeting must meet the eligibility requirements below:

  • Scientific material must be original. 
  • Abstracts are not eligible for consideration if the paper has been presented at a major national or international meeting prior to the USCAP 2019 Annual Meeting, March 16-21, 2019.
  • Abstracts cannot be previously published, online or in print, prior to the USCAP 2019 Annual Meeting, March 16-21, 2019.
  • If the accepted abstract is also submitted as a manuscript for publication, authors are responsible for coordinating a publication date that abides by the Academy’s embargo policy. If publication occurs online or in print before the USCAP 2019 Annual Meeting, March 16-21, 2019, the abstract must be withdrawn. Please notify the Academy via e-mail at support@uscap.org.
  • If you choose to submit a manuscript to the following journals prior to the abstract presentation in March 2019, you will need to indicate this on your submission form and in a cover letter on your journal submission. USCAP has an agreement with these journals to withhold approved manuscripts from publication until the embargo is lifted.
       -Modern Pathology 
       -Laboratory Investigation
       -Human Pathology
  • All abstracts must follow USCAP’s embargo policy. Any abstract found to be presented or published prior to the USCAP 2019 Annual Meeting, March 16-21, 2019 will be removed from the program.
  • USCAP will run all abstracts through a plagiarism checker to verify the originality of the work. 
Author Eligibility
  • Individuals may submit as many abstracts as they wish; however, no more than three abstracts will be accepted from any first author. If more than three first author abstracts are submitted, only the three highest scored abstracts will be accepted.
  • Individuals may serve as a coauthor on an unlimited number of abstracts.
Submission Requirements

Contact Information
Provide your full name, academic degree(s), institution, address (including city and country), and email address. Only the first author and primary contact will receive future correspondence from USCAP regarding the status of the abstract.

Abstract Details

  1. 1. The abstract title must be in Title Case.
  1. 2. Enter the full names for all authors.
  1. 3. Enter affiliated institution, city, and country.
  1. 4. Authors will have 264 characters (including spaces) to complete the abstract title. Authors will have 2500 characters (including spaces) to complete the abstract background, design, results, and conclusion. The program will not allow you to submit your abstract unless it fits the defined space. There is no limit on the number of authors. Authors and affiliations will not deduct from the character count on the abstract. 
  1. 5. The abstract should be divided into the following: Background, Design, Results, and Conclusion. The submission program provides you with the ability to enter information in each of these sections and displays them on the final abstract form in this manner. These headings will appear automatically - do not type them in.
  1. 6. Abstracts are blinded for review. Please do not include identifying information in the body of the abstract (such as institutional names).
  1. 7. In addition to text allotments described above, tables and figures are permitted. Guidelines are enumerated below:
  • Figures
    -Maximum of 2 figures per abstract submission
    -Width - 3.75 inches
    -Height - no more than 4 inches tall
    -Maximum file size cannot exceed 3MB
    -Images must be high resolution, 300 DPI, RGB
    -Only jpg (jpeg) or png formats are allowed
    -Once you upload a Figure, you can update it by uploading a different file to the same location or delete by selecting the Delete Figure button.
  • Table
    -Maximum of 1 table per abstract submission. Text in the table will not deduct from the character count.
    -Width - 3.75 inches
    -Height - no restrictions
    -Font - Helvetica/Arial no less than 5pt
  1. 8. Standard abbreviations are acceptable. A special abbreviation should be placed in parentheses after the first appearance of the full word for which it stands. Greek and mathematical symbols are provided in the character map within the program.
  1. 9. Generic drug names are preferred and should be written without capitals. If a proprietary drug name is used, the first letter should be capitalized.
  1. 10. Abstracts can be edited up to the point of the submission deadline and closure of the abstract submission site. There is no final submit button.

Presentation Type

Check Poster Only or Either Poster or Platform on the Submit Abstract page. The Abstract Assignment Committee will make the final determination between poster and platform session. Assignments reflect the scientific merit of the abstract and the Committee’s opinion regarding the most effective presentation method.

  • Poster Presentations - There are six poster sessions over the course of three days. Posters will be on display for half days on Monday, Tuesday or Wednesday. Authors are expected to be at their posters during the morning and afternoon breaks.
  Date Time of Break
  Monday, March 18 9:30 - 11:00 AM
    3:00 - 4:30 PM
Tuesday, March 19
9:30 - 11:00 AM
    2:45 - 4:00 PM
Wednesday, March 20
9:30 - 11:00 AM
    2:30 - 4:00 PM


  • Platform Presentations - Each platform presentation is limited to fifteen (15) minutes, this includes ten (10) minutes for the presentation and five (5) minutes for questions. All platform presentations must utilize digital/electronic projection using Microsoft PowerPoint.


Abstracts must be submitted in one of the categories listed below. Abstracts submitted to an inappropriate category will be reassigned accordingly.


• Autopsy


• Infectious Disease Pathology


• Bone and Soft Tissue Pathology


• Informatics 


• Breast Pathology


• Medical Renal Pathology
  (including Transplantation)


• Cardiovascular Pathology


• Liver Pathology


• Cytopathology


• Neuropathology and
  Ophthalmic Pathology


• Dermatopathology


• Pancreas, Gallbladder, Ampulla,
  and Extra-Hepatic Biliary Tree


• Education

• Endocrine Pathology


• Pathobiology
  (including Pan-genomic/
  Pan-proteomic approaches to cancer)


• Gastrointestinal Pathology


• Pediatric Pathology


• Genitourinary Pathology
  (including Renal tumors)


• Pulmonary Pathology
  (Including Mediastinum)


• Gynecologic and
  Obstetric Pathology


• Quality Assurance


• Head and Neck Pathology


• Techniques (including Ultrastructure)


• Hematopathology





Stowell-Orbison Awards and Autopsy or Surgical Pathology Awards for Pathologists-in-Training

Application information must be completed online through the abstract submission system. In order to be eligible for these awards, applicants must meet all of the following requirements:

  • First author must be a pathologist-in-training
  • Applicants can submit only one first-author abstract for award consideration
  • Upload a verification of eligibility

Detailed award information is available here.

Abstracts accepted for consideration of Stowell-Orbison Awards and/or the Surgical and Autopsy Pathology Awards, will be presented as posters on Monday morning of the USCAP Annual Meeting. Abstracts that are submitted for this competition, but not accepted, will automatically be considered for acceptance as a regular abstract according to subspecialty.

Financial Disclosures

USCAP has zero tolerance for any commercial bias in abstracts and the content must be presented objectively. Reviewers are instructed to reject any abstract which does not meet these criteria. 

Each author must complete an Author Disclosure Form for each abstract submitted; this can be done as early as the date that the submission site opens. No abstract will be accepted for review without complete disclosure forms from all authors. Authors must note any relationships with companies whose products and/or services are discussed in the abstract. All relationships will be disclosed to the audience. 

This policy is not intended to prevent authors with commercial relationships from making a presentation. Disclosure is required to help maintain objectivity and allow audience members to form their own judgments regarding the merit of material presented with the benefit of full disclosure of facts.

Policy on Unlabeled/Off-Label Use
USCAP has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). USCAP requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. All references to unlabeled/off-label use of products in the abstract must be disclosed on the poster when presented.

Abstracts from Industry

  • Abstract must report only research findings. No advertising or product identification by brand name is allowed.
  • Commercial, product, and company logos cannot be placed on posters or poster boards.
  • Posters that contain any type of commercial promotion, as described above, will be removed from the poster hall immediately without notice to the presenter.
  • All posters presented by industry must include a disclosure statement.
Abstract Fee

There is a $45 non-refundable processing fee for each abstract submission. Credit card payment must be made by selecting Pay & Submit. Payment must be made in order to complete the submission process. 

Notification of receipt will be emailed to the primary contact following the payment. NOTE: It is your responsibility to contact USCAP if you do not receive confirmation of abstract receipt within 1 business day. USCAP will be able to confirm receipt of your abstract or will assist you to ensure that your abstract has been completed.

Submission Deadlines

Only electronic submissions will be accepted. To be eligible for review:

  • Submission must be received by Thursday, September 27, 2018; 12:00 PM Noon, Central Daylight Time
  • The abstract fee must be paid prior to the abstract deadline
  • All authors and co-authors must have completed an Author Disclosure Form for each abstract.

Notification of acceptance or rejection will be sent to the first author and primary contact by e-mail in early November; authors will not receive any notifications by mail. A second notification specifying presentation type and further details about the presentation will be sent to the first author and primary contact in late November. If you do not receive an e-mail by mid-December please login to the Abstract Submission site with the login credentials used to create the submission and select the View Final Status button.

If an abstract is accepted, the presenting author is required to register for the USCAP 2019 Annual Meeting and pay the general registration fee. Online registration will be available on the USCAP website November 1, 2018. All registrations must be completed online. Register early as fees for early registration are discounted.

USCAP Embargo Policy

Unless otherwise noted, all abstracts presented at the USCAP Annual Meeting are embargoed until the date and time of presentation. They cannot be presented in any national or international forum or be published (online of print) in abstract or manuscript form prior to first day of the USCAP annual meeting. USCAP reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during the USCAP Annual Meeting.


view more